Back to top

Analyst Blog

Zacks Equity Research

McKesson a Step Closer to PSS World

MCK

 ZacksTrade Now

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

 

McKesson Corporation (MCK - Analyst Report) recently announced that it has received a notification of early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, in relation with its proposed acquisition of PSS World Medical Inc. .

On October 25, 2012, McKesson had announced the signing of a definitive agreement with PSS World Medical Inc., whereby the former will acquire all outstanding shares of PSS World Medical for $29.00 per share in cash.

The termination of this waiting period brings McKesson a step closer to completing its acquisition of PSS World Medical.

Including PSS World Medical's debt of about $480 million and related transaction costs, the acquisition was valued at approximately $2.1 billion. Once the acquisition goes through, PSS World Medical will combine with McKesson’s Medical Surgical Distribution business.

McKesson’s Medical Surgical Distribution business provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers including physicians’ offices, surgery centers, extended care facilities, homecare and occupational health sites through a network of 28 distribution centerswithin the U.S.

The addition of PSS World Medical to the company’s product line will amalgamate distribution capabilities along with product and technology expertise of both the businesses, thereby bolstering the Medical Surgical Distribution business of McKesson, which accounted for a meagre 3% of total sales in 2011.

At the time of announcing the acquisition, McKesson had said that it expects to generate more than $100 million in annual savings (pre-tax) by the fourth year after the closure of the deal. On the second quarter 2013 conference call, the company stated that the deal is expected to add 15 to 25 cents per share to the company's bottom line after a year of closing.

We note that McKesson has been quite active on the acquisition front to boost its organic growth. Last month, the company inked a deal with Emendo Ltd. to acquire the latter. Emendo has developed CapPlan, which is utilized in more than 40 hospitals across New Zealand, Australia, Canada and the UK to optimize operational efficiency by forecasting patient demand and plan resourcing.

We currently have a Neutral recommendation on McKesson. Our recommendation is supported by a Zacks #3 Rank (Hold) in the short run. 

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
DIXIE GROUP DXYN 15.84 +7.90%
BOFL HOLDING BOFI 85.30 +4.97%
RAMBUS INC RMBS 12.31 +4.41%
VIPSHOP HOLD VIPS 148.73 +4.35%
NETFLIX INC NFLX 345.74 +4.32%